| __timestamp | Grifols, S.A. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 180753000 | 396000000 |
| Thursday, January 1, 2015 | 224193000 | 364000000 |
| Friday, January 1, 2016 | 197617000 | 376000000 |
| Sunday, January 1, 2017 | 288320000 | 382000000 |
| Monday, January 1, 2018 | 240661000 | 432000000 |
| Tuesday, January 1, 2019 | 276018000 | 457000000 |
| Wednesday, January 1, 2020 | 294216000 | 463000000 |
| Friday, January 1, 2021 | 354881000 | 508000000 |
| Saturday, January 1, 2022 | 361140000 | 539000000 |
| Sunday, January 1, 2023 | 330551000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical industry, innovation is the key to staying ahead. Zoetis Inc. and Grifols, S.A., two giants in the sector, have shown distinct approaches to research and development (R&D) spending over the past decade. From 2014 to 2023, Zoetis Inc. consistently outpaced Grifols, S.A. in R&D investment, with an average annual increase of approximately 5% compared to Grifols' 3%. Notably, in 2023, Zoetis Inc. allocated 614 million USD to R&D, marking a 55% increase from 2014, while Grifols, S.A. saw an 83% rise, reaching 331 million USD. This trend underscores Zoetis Inc.'s commitment to innovation, as it consistently invests more in R&D, reflecting its strategic focus on developing cutting-edge solutions. As the industry continues to evolve, these investments will likely play a crucial role in shaping the future of healthcare.
Research and Development Expenses Breakdown: AbbVie Inc. vs Grifols, S.A.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Grifols, S.A.
Research and Development Expenses Breakdown: Sanofi vs Grifols, S.A.
Research and Development: Comparing Key Metrics for Zoetis Inc. and Viatris Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Zoetis Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: argenx SE vs Grifols, S.A.
Research and Development Investment: Genmab A/S vs Grifols, S.A.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Grifols, S.A.
Research and Development Expenses Breakdown: Ascendis Pharma A/S vs Grifols, S.A.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Grifols, S.A.
Research and Development Expenses Breakdown: Grifols, S.A. vs CymaBay Therapeutics, Inc.